(Q36821507)

16 August 2017

title

Therapy of pulmonary arterial hypertension in systemic sclerosis: an update (English)

1 reference

16 August 2017

main subject

arterial hypertension

1 reference

Christopher P Denton

1

1 reference

16 August 2017

Svetlana I Nihtyanova

series ordinal

2

1 reference

16 August 2017

publication date

1 May 2007

1 reference

Current Rheumatology Reports

16 August 2017

published in

1 reference

16 August 2017

volume

9

1 reference

16 August 2017

issue

2

1 reference

16 August 2017

page(s)

158-164

1 reference

https://scigraph.springernature.com/pub.10.1007/s11926-007-0011-4

16 August 2017

exact match

0 references

cites work

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11926-007-0011-4

Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11926-007-0011-4

Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11926-007-0011-4

Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions.

21 January 2018

1 reference

12 December 2020

Favorable effects of inhaled treprostinil in severe pulmonary hypertension: results from randomized controlled pilot studies.

1 reference

12 December 2020

The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study).

1 reference

12 December 2020

Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension

1 reference

12 December 2020

Sildenafil citrate therapy for pulmonary arterial hypertension

1 reference

12 December 2020

Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach

1 reference

12 December 2020

Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines

1 reference

12 December 2020

Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan

1 reference

12 December 2020

Inhaled iloprost for severe pulmonary hypertension

1 reference

12 December 2020

Significance of plasma N-terminal pro-brain natriuretic peptide in patients with systemic sclerosis-related pulmonary arterial hypertension

1 reference

12 December 2020

Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2.

1 reference

12 December 2020

Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis

1 reference

12 December 2020

L'hypertension artérielle pulmonaire associée à la sclérodermie systémique : proposition d'un algorithme échocardiographique de dépistage pour un diagnostic précoce (ItinérAIR–Sclérodermie)

1 reference

12 December 2020

Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells

1 reference

12 December 2020

Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension

1 reference

12 December 2020

Pulmonary clearance of circulating endothelin-1 in dogs in vivo: exclusive role of ETB receptors

1 reference

12 December 2020

Sitaxsentan therapy for pulmonary arterial hypertension

1 reference

12 December 2020

The role of endothelin in connective tissue diseases

1 reference

12 December 2020

Efficacy and safety of treprostinil: an epoprostenol analog for primary pulmonary hypertension

1 reference

12 December 2020

The endothelin system in pulmonary arterial hypertension

1 reference

12 December 2020

Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension

1 reference

12 December 2020

Combination therapy with bosentan and sildenafil in idiopathic pulmonary arterial hypertension

1 reference

12 December 2020

Beraprost therapy for pulmonary arterial hypertension

1 reference

12 December 2020

Goal-oriented treatment and combination therapy for pulmonary arterial hypertension

1 reference

12 December 2020

Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology

1 reference

12 December 2020

Systemic sclerosis associated pulmonary hypertension: improved survival in the current era.

1 reference

12 December 2020

Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis

1 reference

12 December 2020

STRIDE 1: effects of the selective ET(A) receptor antagonist, sitaxsentan sodium, in a patient population with pulmonary arterial hypertension that meets traditional inclusion criteria of previous pulmonary arterial hypertension trials.

1 reference

12 December 2020

Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survival

1 reference

12 December 2020

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study

1 reference

12 December 2020

Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease.

1 reference

12 December 2020

Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) study

1 reference

12 December 2020

Efficacy of long-term subcutaneous treprostinil sodium therapy in pulmonary hypertension

1 reference

12 December 2020

Bosentan therapy for pulmonary arterial hypertension

1 reference

12 December 2020

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

1 reference

12 December 2020

Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension: a 1-year follow-up study

1 reference

12 December 2020

Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension.

1 reference

12 December 2020

Immunosuppressive Therapy in Connective Tissue Diseases-Associated Pulmonary Arterial Hypertension

1 reference

12 December 2020

Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.

1 reference

12 December 2020

Survival in primary pulmonary hypertension: the impact of epoprostenol therapy.

1 reference

12 December 2020

Cellular and molecular pathobiology of pulmonary arterial hypertension

1 reference

12 December 2020

10.1007/S11926-007-0011-4

Identifiers

DOI

1 reference

16 August 2017

1 reference